Phenopath Laboratories PLLC
Phenopath Laboratories PLLC is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
A Phase 2 study of alisertib in combination with endocrine therapy in patients with HR+, HER2-negative recurrent or metastatic breast cancer
Sponsor Puma Biotechnology Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Ciltacabtagene Autoleucel versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in Participants with Newly Diagnosed Multiple Myeloma who are Transplant Eligible
Sponsor European Myeloma Network B.V.
- Start (EU)
- Latest update
- Estimated end
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation – MajesTEC-4
Sponsor European Myeloma Network B.V.
- Start (EU)
- Latest update
- Estimated end
An Open-label, Multicenter, Phase 2 Dose Optimization and Expansion Study to Evaluate the Safety and Efficacy of BB-1701, an anti-human epidermal growth factor receptor 2 (anti-HER2) antibody-drug conjugate (ADC), in Previously Treated Subjects with HER2-positive or HER2-low Unresectable or Metastatic Breast Cancer
Sponsor Eisai Limited
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Phenopath Laboratories PLLC?
The 2026-10-09 snapshot links Phenopath Laboratories PLLC to 4 distinct CTIS trials. Recorded services include Laboratory services, : BIOPSY KIT : New malignancies (SPM), Plasmacytoma, Neurotoxicity event or any other time a biopsy, biomarker analysis (soft tissue plasmacytoma biopsy), Biomarker Analysis for Tissue. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Phenopath Laboratories PLLC?
The most frequently recorded therapeutic areas are Haematological Malignancies, Solid Tumor Oncology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Phenopath Laboratories PLLC conducted?
The linked trials record locations in 15 countries, including Germany, Spain, France, Belgium, Czechia. These are trial locations, not confirmed office locations or countries where Phenopath Laboratories PLLC delivered services.
What can this page tell me about Phenopath Laboratories PLLC's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Phenopath Laboratories PLLC. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Phenopath Laboratories PLLC